Exceedingly biocompatible and thin-layered reduced graphene oxide nanosheets and its application in co-delivery of curcumin and paclitaxel shows highly potent synergistic anticancer effects in A549 and MDA-MB-231 cells
Delivery of anti-cancer drugs using graphene and its derivatives: graphene oxide (GO) and reduced graphene oxide (RGO) has sparked major interest in this emerging field. The anti-cancer therapies often pose a limitation of insolubility, administration problems and cell-penetration ability. In additi...
| Main Author: | |
|---|---|
| Published: |
University of Nottingham
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734364 |